Status:
COMPLETED
Preventive Osteopathic Treatment of Plagiocephaly
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Positilonal Deformation of the Skull
Head Turn Preference
Eligibility:
All Genders
3-11 years
Phase:
NA
Brief Summary
Positional cranial deformities (PCD), plagiocephaly and brachycephaly are a common reason for pediatric consultation, which has increased significantly since the recommendation to lay babies on their ...
Eligibility Criteria
Inclusion
- Newborn baby aged 3 days and until the maternity leave
- Newborn with at least one risk factor for cranial deformity:
- Newborn who received instrumental vaginal delivery.
- Newborn presenting:
- a preferential side,
- global axial hypertonia,
- Localized suboccipital hypertonia
- Newborn presenting:
- cranial deformity at birth,
- a deformation of the face,
- deformity of the trunk in scoliosis, comma or hyperextension
Exclusion
- Newborn with congenital muscular torticollis (managed directly in physiotherapy)
- Premature neonate (\<37SA)
- Newborn with a malformation pathology
- Newborn with craniosynostosis.
- Newborn with a contraindication to the practice of osteopathy.
Key Trial Info
Start Date :
February 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2022
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03780920
Start Date
February 14 2019
End Date
January 21 2022
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Arnaud de Villeneuve
Montpellier, Hérault, France, 34000